| Institution: | 1. Section on Neuroendocrine Immunology & Behavior, National Institute of Mental Health/NIH, Bethesda, Maryland;2. Howard Hughes Medical Institutions, Bethesda, Maryland;3. Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland;1. Laboratory of Pharmacology, Instituto Butantan, São Paulo, Brazil;2. Section of Experimental Endocrinology, Department of Pharmacology, Escola Paulista de Medicina-Universidade Federal de São Paulo, São Paulo, Brazil;1. Duke Brain Tumor Immunotherapy Program, Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC;2. Department of Biomedical Engineering, Duke University, Durham, NC;3. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC;4. Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA;1. S3 119, Schurman Hall, College of Veterinary Medicine, Cornell University, Ithaca, NY 14850, USA;2. Department of Population Medicine & Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA;3. GD Animal Health, Deventer, The Netherlands;4. Department of Animal Sciences, Wageningen University, Wageningen,The Netherlands;1. Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece |
